ArticleIn vivo (Athens, Greece)

Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis.

Michelangelo Russillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.